Treatment Strategies and Survival Outcomes in Breast Cancer
Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and t...
Saved in:
| : | |
|---|---|
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (264 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993548397804498 |
|---|---|
| ctrlnum |
(CKB)4100000011302294 (oapen)https://directory.doabooks.org/handle/20.500.12854/61309 (EXLCZ)994100000011302294 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Cheung, Kwok-Leung auth Treatment Strategies and Survival Outcomes in Breast Cancer MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (264 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy). Advances in technologies such as oncoplastic surgery, radiation planning and delivery, and genomics, and the development of novel systemic therapy agents alongside their evaluation in ongoing clinical trials continue to strive for improvements in outcomes. In this Special Issue, we publish a collection of studies looking at all forms of therapeutic strategies for early and advanced breast cancer, focusing on their outcomes, notably survival. English relative survival young women cancer treatment fulvestrant lapatinib tumor biology antihormone therapy mastectomy aromatase inhibitors chemotherapy serum biomarker cyclin E anthracycline resistance zero-inflated Poisson regression model lymph-node ratio CHEK2 comparative effectiveness breast-conserving therapy taxane sensitivity liquid biopsy HER2 c-erbB2 colorectal cancer infiltrating breast cancer survival exercise characteristics lactate dehydrogenase biomarker breast cancer survivors BRCA disease-free survival PIK3CA metastatic breast cancer cell-free DNA invasive breast cancer radiotherapy Metformin social well-being gene expression contralateral breast cancer basal-like breast cancer LMK-235 Src kinase HER2/neu LKB1 Older women LDH mutation carriers stage IV mammography screening NCDB cMet SEER pertuzumab physical function outcome ribociclib older patients geriatric oncology metastatic overdiagnosis next-generation sequencing abemaciclib Endocrine therapy monitoring metastatic breast cancer breast cancer circulating tumor cells Breast Cancer PALB2 histone deacetylase prognosis physical activity trastuzumab ductal carcinoma in situ contralateral prophylactic mastectomy ERCC1 family history T-DM1 ATM advanced breast cancer incidence palbociclib HDAC5 inhibitors APOBEC3B 3-03928-758-3 |
| language |
English |
| format |
eBook |
| author |
Cheung, Kwok-Leung |
| spellingShingle |
Cheung, Kwok-Leung Treatment Strategies and Survival Outcomes in Breast Cancer |
| author_facet |
Cheung, Kwok-Leung |
| author_variant |
k l c klc |
| author_sort |
Cheung, Kwok-Leung |
| title |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| title_full |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| title_fullStr |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| title_full_unstemmed |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| title_auth |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| title_new |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| title_sort |
treatment strategies and survival outcomes in breast cancer |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2020 |
| physical |
1 electronic resource (264 p.) |
| isbn |
3-03928-759-1 3-03928-758-3 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT cheungkwokleung treatmentstrategiesandsurvivaloutcomesinbreastcancer |
| status_str |
n |
| ids_txt_mv |
(CKB)4100000011302294 (oapen)https://directory.doabooks.org/handle/20.500.12854/61309 (EXLCZ)994100000011302294 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Treatment Strategies and Survival Outcomes in Breast Cancer |
| _version_ |
1787551667686735873 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04207nam-a2201261z--4500</leader><controlfield tag="001">993548397804498</controlfield><controlfield tag="005">20231214133259.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03928-759-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000011302294</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/61309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000011302294</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cheung, Kwok-Leung</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment Strategies and Survival Outcomes in Breast Cancer</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (264 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy). Advances in technologies such as oncoplastic surgery, radiation planning and delivery, and genomics, and the development of novel systemic therapy agents alongside their evaluation in ongoing clinical trials continue to strive for improvements in outcomes. In this Special Issue, we publish a collection of studies looking at all forms of therapeutic strategies for early and advanced breast cancer, focusing on their outcomes, notably survival.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">relative survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">young women</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fulvestrant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lapatinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor biology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antihormone therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mastectomy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aromatase inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serum biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cyclin E</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anthracycline resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">zero-inflated Poisson regression model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lymph-node ratio</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CHEK2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">comparative effectiveness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast-conserving therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">taxane sensitivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HER2 c-erbB2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infiltrating breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exercise characteristics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lactate dehydrogenase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer survivors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRCA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease-free survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PIK3CA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-free DNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasive breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Metformin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">social well-being</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">contralateral breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">basal-like breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LMK-235</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Src kinase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HER2/neu</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LKB1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Older women</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LDH</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mutation carriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stage IV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mammography screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NCDB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cMet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SEER</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pertuzumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">physical function</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">outcome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ribociclib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">older patients</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">geriatric oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">overdiagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">next-generation sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">abemaciclib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Endocrine therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">monitoring metastatic breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating tumor cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Breast Cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PALB2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">histone deacetylase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">physical activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trastuzumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ductal carcinoma in situ</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">contralateral prophylactic mastectomy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ERCC1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">family history</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T-DM1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ATM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">advanced breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">incidence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">palbociclib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HDAC5 inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">APOBEC3B</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-758-3</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:49:05 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-06-20 22:16:43 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338781930004498&Force_direct=true</subfield><subfield code="Z">5338781930004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338781930004498</subfield></datafield></record></collection> |